Stockscreener 앱 받기
13.79
13.72%
1.77
시간 외 거래:
13.80
0.01
+0.07%
Neurogene Inc 주식(NGNE)의 최신 뉴스
Analysts Set Neurogene Inc. (NASDAQ:NGNE) Price Target at $47.20 - Defense World
Wellington Management Group LLP Grows Stock Holdings in Neurogene Inc. (NASDAQ:NGNE) - The AM Reporter
BMO cuts Neurogene stock target to $16 from $45, keeps Outperform By Investing.com - Investing.com South Africa
Wellington Management Group LLP Increases Stock Holdings in Neurogene Inc. (NASDAQ:NGNE) - Defense World
JPMorgan Chase & Co. Purchases 476,418 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene (NASDAQ:NGNE) Given New $16.00 Price Target at BMO Capital Markets - Defense World
Neurogene Inc. Amends Agreement, Issues Warrants By Investing.com - Investing.com South Africa
Neurogene Inc. Amends Agreement, Issues Warrants - Investing.com
Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold - marketscreener.com
BMO cuts Neurogene stock target to $16 from $45, keeps Outperform - Investing.com Canada
NGNE stock touches 52-week low at $8.35 amid market challenges - Investing.com Australia
NGNE stock touches 52-week low at $8.35 amid market challenges By Investing.com - Investing.com South Africa
Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome - BioSpace
Neurogene reports progress in gene therapy regulation technology By Investing.com - Investing.com Canada
Neurogene reports progress in gene therapy regulation technology - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Investors to Inquire about Securities Investigation - ACCESS Newswire
Revolutionary Gene Therapy Technology Successfully Controls Rett Syndrome Treatment in Major Study - Stock Titan
Q1 Earnings Estimate for Neurogene Issued By HC Wainwright - The AM Reporter
What is Leerink Partnrs’ Forecast for Neurogene Q1 Earnings? - Defense World
Neurogene Inc. (NASDAQ:NGNE) Receives $59.80 Average PT from Brokerages - Defense World
What is William Blair’s Forecast for Neurogene Q1 Earnings? - Defense World
What is HC Wainwright’s Estimate for Neurogene Q1 Earnings? - Defense World
Neurogene Reports 2024 Financial Results and Advances in Rett Syndrome Trial - MSN
PNC Financial Services Group Inc. Makes New $71,000 Investment in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Analyzing Neurogene (NASDAQ:NGNE) & Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Neurogene (NASDAQ:NGNE) Receives Outperform Rating from William Blair - Defense World
Stifel maintains Buy on Neurogene stock with $46 target By Investing.com - Investing.com UK
Neurogene (NASDAQ:NGNE) Given New $50.00 Price Target at HC Wainwright - Defense World
Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates - BioSpace
Neurogene Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Neurogene Inc. (NGNE) reports earnings - Quartz
Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 MillionSEC Filing -March 24, 2025 at 04:38 pm EDT - MarketScreener
Neurogene Inc (NASDAQ: NGNE): Overvalued Compared To Others? - Stocks Register
Insiders Re-Evaluate Their US$1.46m Stock Purchase As Neurogene Falls To US$251m - simplywall.st
NEUROGENE Earnings Preview: Recent $NGNE Insider Trading, Hedge Fund Activity, and More - Nasdaq
Rhumbline Advisers Buys 1,326 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene: Potential To Target Root Cause Of Rett Syndrome With NGN-401 - Seeking Alpha
Neurogene (NASDAQ:NGNE) Shares Down 8.4% – Here’s Why - Defense World
Neoleukin Therapeutics, Inc. Announces Reduction in the Workforce -March 08, 2023 at 05:00 pm EST - marketscreener.com
Neurogene to Participate in Upcoming Conferences - Business Wire
Can These 3 Healthcare Conferences Reveal Neurogene's Next Big Move? - Stock Titan
Neurogene Insiders Placed Bullish Bets Worth US$1.46m - Yahoo Canada Finance
Neurogene (NGNE) to Release Quarterly Earnings on Monday - Defense World
Neurogene (NGNE) Projected to Post Quarterly Earnings on Monday - MarketBeat
Neurogene Inc (NGNE) Shares Decline Despite Market Challenges - The News Heater
Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Stockholders to Connect - accessnewswire.com
Should You Expect Neurogene Inc (NASDAQ:NGNE) To Recover From Its 38.11% Gain From Highs? - Marketing Sentinel
Get in on Neurogene Inc’s (NGNE) buy-in window today! - SETE News
Neurogene Inc [NASDAQ: NGNE] Sees Increase in Stock Value - Knox Daily
1.75%
2.22%
자본화:
|
볼륨(24시간):